Fundz

Gx Molecular Inc. reported raising $2.23 Million in an initial SEC Form D filing, from an offering of $2.23 Million

PRIVATEJun 10, 2021

Amount Raised

$2.23 Million

$2.23 Million sold, per SEC Form D (first sale Jun 10, 2021)

Round Type

Seed

United KingdomInformation TechnologyBiotechnology

Quick answer

GX Molecular raised $2.23 Million in a Seed round, dated June 10, 2021. GX Molecular is based in United Kingdom.

How much did GX Molecular raise?
GX Molecular raised $2.23 Million in a Seed round on June 10, 2021.
What does GX Molecular do?
BioGx Open Source Reagents (OSRs) Diagnostics service offers laboratories an excellent option to outsource manufacturing of their Laboratory Developed Tests (LDTs).
Where is GX Molecular based and how big is it?
GX Molecular is based in United Kingdom.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as GX Molecular that raised within 45 days of this round, from Fundz verified event records.

  • Transcera Inc. raised $1M (Seed) on July 23, 2021.
  • Wugen raised $99M on July 23, 2021.
  • Wugen raised $37M on July 23, 2021.
  • Arzeda raised $26M on July 22, 2021.
  • Kandu Health™ raised $260M on July 22, 2021.
  • Phytoform raised $5.5M on July 22, 2021.

Who to call at GX Molecular, and when

A new round usually means GX Molecular is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day GX Molecular raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at GX Molecular, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at GX Molecular. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

GX Molecular

Location

WEWORK 50-60 STATION ROAD

United Kingdom

About

BioGx Open Source Reagents (OSRs) Diagnostics service offers laboratories an excellent option to outsource manufacturing of their Laboratory Developed Tests (LDTs).

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment GX Molecular raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for GX Molecular's next move

See what Strategic adds

GX Molecular raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.